Question 1

Does Bank of New York Mellon own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Bank of New York Mellon holds 197,226 shares of AXSM (Axsome Therapeutics), worth $48.3M.

Question 2

How many shares of AXSM does Bank of New York Mellon own?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon holds 197,226 shares of AXSM (Axsome Therapeutics).

Question 3

What is Bank of New York Mellon's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon's AXSM position is worth $48.3M.

Question 4

Is Bank of New York Mellon buying or selling AXSM?

Accepted Answer

In Q2 2026, Bank of New York Mellon reduced its AXSM position by 9,418 shares (-4.6%).

Question 5

When did Bank of New York Mellon first buy AXSM?

Accepted Answer

Bank of New York Mellon already held AXSM in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	197,226	-4.6%	$48.3M	0.0%	$244.77	0
2026-Q1	Decreased	206,644	-19.0%	$34.9M	0.0%	$169.02	0
2025-Q4	Increased	255,097	+0.7%	$46.6M	0.0%	$182.64	29
2025-Q3	Increased	253,263	+24.4%	$30.8M	0.0%	$121.45	35
2025-Q2	Increased	203,632	+55.4%	$21.3M	0.0%	$104.39	40
2025-Q1	Decreased	131,023	-2.6%	$15.3M	0.0%	$116.63	0
2024-Q4	Decreased	134,550	-1.4%	$11.4M	0.0%	$84.61	0
2024-Q3	Decreased	136,446	-17.6%	$12.3M	0.0%	$89.87	0